Mpox isn't gone. It continues to circulate at lower levels, with the highest impact going to people who are unvaccinated or only partially vaccinated. Check out our newest policy aid below for more on what you can do to help.
This policy aid is designed to help address disparities in mpox vaccination rates by highlighting practical, replicable strategies to improve vaccine awareness, access, and uptake. It examines approaches implemented across four jurisdictions—Vermont, New York City, Chicago and Houston—and outlines the background and tactics from each location. The goal is to support health departments, clinics, and other public health agencies with incorporating mpox vaccination into existing programs and services.
Strategy One: Leverage DIS Expertise and Infrastructure
Vermont Department of Health
Strategy Two: Enhance Clinical Strategies for Vaccine Demand
Callen-Lorde, NYC
Strategy Three: Create Opportunities for Community Engagement and Second Doses
Chicago Department of Health
Strategy Four: Partner with Pharmacies
Legacy Community Health, Houston
NCSD would like to thank its partners in the STI sector who agreed to be interviewed for the development of this policy aid, which includes Dr. Kevin Aloysius, Daniel Daltry, Dr. Demetre Daskalakis, Kevin Hansen, and Elsbet Servay. This project was developed by NCSD and is supported by Bavarian Nordic. The contents of this aid are those of the authors and do not necessarily represent the official views or endorsements of the funder.
For questions related to this policy aid, please contact NCSD’s policy team at [email protected]